COMMUNIQUÉS West-GlobeNewswire

UPDATE: Westleaf Inc. Going Public Wednesday, January 9th -- CFN Media
08/01/2019
Seattle, WA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
OnePoint Patient Care Opens Hospice-Dedicated Pharmacy in Orlando
08/01/2019
Second Florida-based pharmacy provides expert local dispensing for Central Region MORTON GROVE, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- OnePoint Patient Care, the market leader in local hospice pharmacy and e- [...]
ERC-USA Initiates Therapy Under Right to Try Law With First Patient In California Using Investigational Compound ERC1671 for Treatment of Glioblastoma
08/01/2019
IRVINE, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine have initiated treatment with the company’s investigational compound ERC1671, also known in Europe as Gliovac, which is [...]
Diamond CBD Enters $21 Billion Vending Machine Market With Innovative Hemp-Derived CBD Product Showcase at CES 2019
08/01/2019
Booth Co-Hosted with interactive vending machine partner CloudPay Technologies to be the only CBD brand available at world's most influential consumer electronics event MIAMI, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via OTC [...]
Westleaf Inc. Going Public Wednesday, January 9th -- CFN Media
08/01/2019
Seattle, WA, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure
08/01/2019
MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that the Centers for [...]
Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children
08/01/2019
PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Cognoa , a digital behavioral health company, announced today that Cambia Health Solutions, Inc . (Cambia) is incorporating Cognoa’s evidence-based platform within [...]
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for ALS
08/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, [...]
Sam’s Club and Dynavax Technologies Corporation Announce Collaboration to Make HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Available to Sam’s Club Patients
08/01/2019
BERKELEY, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX), a leader in developing immunotherapies based on toll-like receptor (TLR) biology, and Sam’s Club, a leading membership [...]
AXIM® Biotechnologies Appoints New Chief Executive Officer
08/01/2019
NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the appointment of John W. [...]
Emblem Oils Now Available Through Shoppers Drug Mart
08/01/2019
TORONTO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced that Emblem-branded cannabis [...]
CTD Holdings’ Senior VP for Medical Affairs Appointed to Committee of the National Academies of Sciences, Engineering, and Medicine
08/01/2019
ALACHUA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
CV Sciences, Inc. Appoints New Chief Accounting Officer
08/01/2019
LAS VEGAS, Jan. 08, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating brand PlusCBD Oil [...]
Merus annonce l'autorisation (IND) pour le MCLA-145
08/01/2019
Le MCLA-145 est un anticorps bispécifique humain complet se liant au PD-L1 et au CD137 UTRECHT, Pays-Bas, 08 janv. 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise d'immuno-oncologie de stade clinique qui [...]
Marrone Bio Innovations Appoints Matthew O. Brecht, Ph.D. as New Cannabis Key Account Manager
08/01/2019
DAVIS, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Matthew O. [...]
Dragon Jade Announces Business Collaboration with KPM Health Centre
08/01/2019
HONG KONG, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced that it has established a [...]
SELLAS Life Sciences Provides Update on Late-Stage Immunotherapy Clinical Development Pipeline
08/01/2019
Aligned with FDA on Phase 3 Registration-Enabling Trial for Galinpepimut-S (GPS) in Acute Myeloid Leukemia; Trial Expected to Start in Q2 2019 Enrollment of Phase 1/2 Basket Trial of GPS plus Keytruda ® (pembrolizumab) [...]
Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring
08/01/2019
Mass cytometry services for pharmaceutical and biotechnology companies to accelerate development of new health insights SOUTH SAN FRANCISCO, Calif. and MONTREAL, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Caprion Biosciences, a [...]
Corvus Announces Enrollment in Second Arm of Phase 1/1b Dose-Escalation Trial of Anti-CD73 Antibody, CPI-006, Focused on Combination with CPI-444 Adenosine Antagonist
08/01/2019
Both CPI-006 monotherapy and CPI-006 in combination with CPI-444 trial arms now enrolling patients at U.S. sites CPI-006 in combination with CPI-444 targets multiple points in the adenosine pathway BURLINGAME, Calif., [...]

Pages